Testosterone Therapy in Middle-Aged and Older Men with Hypogonadism: Balancing Clinical Benefits and Risks

Highlights

  • Testosterone therapy modestly improves sexual function, corrects anemia, and increases bone density in older men with hypogonadism.
  • Risks include increased venous thromboembolism, clinical fractures, and atrial fibrillation; no significant increase in major cardiovascular events or prostate cancer observed in trials to date.
  • Therapy should be reserved for men with unequivocally low testosterone levels and persistent symptoms after careful diagnostic workup.

Study Background and Disease Burden

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply